The United Laboratories International Holdings Limited (HKG:3933)
8.43
-0.25 (-2.88%)
Jun 8, 2026, 4:09 PM HKT
HKG:3933 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,086 | 2,660 | 2,701 | 1,581 | 988.1 |
Depreciation & Amortization | 630.58 | 597.77 | 549.91 | 534.78 | 607.15 |
Other Amortization | 18.96 | 17.78 | 15.74 | 17.66 | 13.7 |
Loss (Gain) From Sale of Assets | -21.04 | 4.27 | 3.7 | 4.39 | 3.3 |
Asset Writedown & Restructuring Costs | 48.59 | 23.3 | 47.96 | 78.18 | 16.08 |
Loss (Gain) From Sale of Investments | -79.38 | -66.5 | -72.75 | -17.97 | - |
Loss (Gain) on Equity Investments | 0.05 | 0.19 | -0.14 | 0.19 | - |
Stock-Based Compensation | 14.09 | 47.36 | 6.37 | - | - |
Provision & Write-off of Bad Debts | 18.66 | 39.25 | 5.62 | -15.47 | 2.61 |
Other Operating Activities | -330.33 | -238.56 | 86.48 | 135.16 | 170.1 |
Change in Accounts Receivable | 983.55 | 429.08 | -1,562 | -392.22 | -860.37 |
Change in Inventory | 77.42 | -179.72 | -118.05 | -158.04 | -577.53 |
Change in Accounts Payable | 322.1 | -115.15 | 792.37 | 238.36 | 1,150 |
Change in Unearned Revenue | -19.33 | -19.47 | -16.9 | 24.43 | 29.83 |
Operating Cash Flow | 3,750 | 3,199 | 2,439 | 2,031 | 1,543 |
Operating Cash Flow Growth | 17.21% | 31.15% | 20.14% | 31.64% | -1.61% |
Capital Expenditures | -2,802 | -1,715 | -1,274 | -779.55 | -482.17 |
Sale of Property, Plant & Equipment | 34.65 | 9.51 | 4.37 | 7.59 | 19.16 |
Sale (Purchase) of Intangibles | -83.96 | -94.73 | -51.07 | - | -5.16 |
Investment in Securities | 79.38 | 67 | 72.75 | 10.62 | - |
Other Investing Activities | 607.05 | 5.29 | -308.51 | 166.42 | -119.06 |
Investing Cash Flow | -2,165 | -1,728 | -1,557 | -594.92 | -587.22 |
Long-Term Debt Issued | 4,037 | 2,228 | 2,044 | 2,952 | 1,394 |
Long-Term Debt Repaid | -2,210 | -591.41 | -2,783 | -2,628 | -1,712 |
Net Debt Issued (Repaid) | 1,827 | 1,636 | -738.93 | 324.21 | -317.84 |
Issuance of Common Stock | 1,990 | - | - | - | - |
Repurchase of Common Stock | -41.42 | -36.47 | - | -42.04 | -40.98 |
Common Dividends Paid | -824.45 | -799.49 | -472.43 | -236.29 | -220.85 |
Other Financing Activities | 46.49 | 14.74 | -42.3 | -33.7 | -41.26 |
Financing Cash Flow | 2,780 | 596.91 | -1,363 | -24.17 | -620.93 |
Foreign Exchange Rate Adjustments | -87.58 | -0.27 | -0.89 | 0.6 | -0.19 |
Net Cash Flow | 4,277 | 2,068 | -481.08 | 1,412 | 334.21 |
Free Cash Flow | 947.32 | 1,484 | 1,165 | 1,251 | 1,060 |
Free Cash Flow Growth | -36.17% | 27.40% | -6.88% | 17.98% | 2.25% |
Free Cash Flow Margin | 7.17% | 10.79% | 8.48% | 11.04% | 10.93% |
Free Cash Flow Per Share | 0.50 | 0.82 | 0.64 | 0.69 | 0.58 |
Cash Interest Paid | 127.26 | 68.4 | 78.43 | 75.62 | 50.46 |
Cash Income Tax Paid | 675.12 | 657.74 | 526.99 | 299.85 | 236.97 |
Levered Free Cash Flow | 1,030 | 1,888 | 187.24 | 619.01 | 496.93 |
Unlevered Free Cash Flow | 1,074 | 1,910 | 229.05 | 670.01 | 534.57 |
Change in Working Capital | 1,364 | 114.74 | -904.8 | -287.46 | -258.5 |